top of page
CELUMIGEN IS UNMATCHED IN ITS STRATEGIC ADVISORS/
EARLY INVESTORS:
SEED INVESTMENT SYNDICATE funded breakthrough confirmatory Proof of Concept study:
Tom Wiggans CEO, Founder of Dermira (sold to Lilly for $1.1B in 2020)
Wilson, Sonsini, Goodrich & Rosati Co- investor, out of Wilson Sonsini Partners Fund
bottom of page